speb/financial-data huggingface dataset:
Financial ratios for FOA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.57
Shares outstanding: 8936570
Market cap (USD): 103396114.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FOA — annual report dated 2024-12-31
Total revenue: 270643000
Net income: 35691000
Capital expenditures: 0
Operating cash flow: -423815000
Depreciation & amortization: 38947000
Net tangible assets: 38957000
Owner earnings: 74638000
Return on net tangible assets (%): 191.59072823882744
Buffett classification: The Gruesome
Stock price: 28.12
P/E ratio: 7.040888414446219
Shares outstanding: 8936570
Book value: 315664000
P/B ratio: 0.7960880822646864
Market cap (USD): 251296348.4
Debt to equity: 90.98177175731158
Effective tax rate (%): 5.600710014947683
COGS to revenue (%): 0
SG&A to revenue (%): 78.2828301489416
Free cash flow (dilution-adjusted): -432627000
Buyback yield (%): 0
Retained earnings: -698895000
Receivables turnover: 4.303913617352862
Capitalized R&D asset: 0
FCF margin (%): -159.85153874291964
Revenue growth (%): 52.878874321446524
Rule of 40 score: -106.97266442147313
Financial ratios for FOA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.12
Shares outstanding: 8936570
Market cap (USD): 251296348.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FOA — quarterly report dated 2025-03-31
Total revenue: 146624000
Net income: 75000000
Capital expenditures: 0
Operating cash flow: -92082000
Depreciation & amortization: 9658000
Net tangible assets: 84568000
Owner earnings: 84658000
Return on net tangible assets (%): 100.10642323337433
Buffett classification: The Gruesome
Stock price: 21.26
P/E ratio: 0.6333049273333333
Shares outstanding: 8936570
Book value: 394886000
P/B ratio: 0.4811299418059896
Market cap (USD): 189991478.20000002
Debt to equity: 72.8741788769417
Effective tax rate (%): 2.3784167554135602
COGS to revenue (%): 0
SG&A to revenue (%): 39.31143605412484
Free cash flow (dilution-adjusted): -92082000
Buyback yield (%): 0
Retained earnings: -668686000
Capitalized R&D asset: 0
FCF margin (%): -62.80145133129638
Rule of 40 score: -62.80145133129638
Financial ratios for FOA — quarterly report dated 2025-06-30
Total revenue: 160389000
Net income: 79823000
Capital expenditures: 0
Operating cash flow: -96473000
Depreciation & amortization: 9654000
Net tangible assets: 127052000
Owner earnings: 89477000
Return on net tangible assets (%): 70.42549507288355
Buffett classification: The Gruesome
Stock price: 23.32
P/E ratio: 1.3460584822668467
Shares outstanding: 8936570
Book value: 473425000
P/B ratio: 0.4401981568358241
Market cap (USD): 208400812.4
Debt to equity: 62.37453239689497
Effective tax rate (%): 2.6014276127142946
COGS to revenue (%): 0
SG&A to revenue (%): 38.917257417902725
Free cash flow (dilution-adjusted): -96473000
Buyback yield (%): 0
Retained earnings: -633763000
Receivables turnover: 2.752514158228934
Capitalized R&D asset: 0
FCF margin (%): -60.149386803334394
Revenue growth (%): 9.387958315146225
Rule of 40 score: -50.76142848818817
Financial ratios for FOA — quarterly report dated 2025-09-30
Total revenue: 47153000
Net income: -9515000
Capital expenditures: 0
Operating cash flow: -149748000
Depreciation & amortization: 9643000
Net tangible assets: 94276000
Owner earnings: 128000
Buffett classification: The Gruesome
Stock price: 22.43
P/E ratio: 1.3794647583064938
Shares outstanding: 8936570
Book value: 365831000
P/B ratio: 0.5479231259789357
Market cap (USD): 200447265.1
Debt to equity: 82.21669568735291
COGS to revenue (%): 0
SG&A to revenue (%): 129.90901957457638
Free cash flow (dilution-adjusted): -149748000
Buyback yield (%): 0
Retained earnings: -643278000
Receivables turnover: 0.7843016583223832
Capitalized R&D asset: 0
FCF margin (%): -317.5789451360465
Revenue growth (%): -70.60085167935458
Rule of 40 score: -388.1797968154011
Financial ratios for FOA — quarterly report dated 2025-12-31
Total revenue: 57801000
Net income: -10382000
Capital expenditures: 0
Operating cash flow: -91443000
Depreciation & amortization: 9640000
Net tangible assets: 144257000
Owner earnings: -742000
Return on net tangible assets (%): -0.5143597884331436
Buffett classification: The Gruesome
Stock price: 24.21
P/E ratio: 1.6035038443294845
Shares outstanding: 8936570
Book value: 395627000
P/B ratio: 0.5468644953453632
Market cap (USD): 216354359.70000002
Debt to equity: 76.31434659414045
COGS to revenue (%): 0
SG&A to revenue (%): 71.77730489091884
Free cash flow (dilution-adjusted): -91443000
Buyback yield (%): 0
Retained earnings: -653660000
Receivables turnover: 0.7861407684461068
Capitalized R&D asset: 0
FCF margin (%): -158.2031452743032
Revenue growth (%): 22.58180815642695
Rule of 40 score: -135.62133711787627
Financial ratios for FOA — annual report dated 2025-12-31
Total revenue: 411967000
Net income: 103039000
Capital expenditures: 0
Operating cash flow: -429746000
Depreciation & amortization: 38595000
Net tangible assets: 144257000
Owner earnings: 141634000
Return on net tangible assets (%): 98.18171735167097
Buffett classification: The Gruesome
Stock price: 24.21
P/E ratio: 2.0997327196498414
Shares outstanding: 8936570
Book value: 395627000
P/B ratio: 0.5468644953453632
Market cap (USD): 216354359.70000002
Debt to equity: 76.31434659414045
Effective tax rate (%): 3.1114883683917345
COGS to revenue (%): 0
SG&A to revenue (%): 54.0827299273971
Free cash flow (dilution-adjusted): -439907000
Buyback yield (%): 18.55705614422153
Retained earnings: -653660000
Receivables turnover: 5.603087385243114
Capitalized R&D asset: 0
FCF margin (%): -106.78209662424419
Revenue growth (%): 52.217866340529774
Rule of 40 score: -54.564230283714416
Financial ratios for HKIT — annual report dated 2023-12-31
Total revenue: 641874.9648382559
Gross profit: 270216.5963431786
Operating income: 94372.57383966244
Net income: 147347.5386779184
Capital expenditures: 26230.52039381153
Operating cash flow: -8707.735583684951
Depreciation & amortization: 7570.886075949366
Net tangible assets: 3985595.780590717
Owner earnings: 128687.90436005623
Return on net tangible assets (%): 3.2288247841576903
Capex to operating income (%): 27.794643429325966
Buffett classification: The Good
Stock price: 157.5
P/E ratio: 854.9715260284775
Shares outstanding: 799860
Book value: 3985595.7805907177
P/B ratio: 31.60831076083897
Market cap (USD): 125977950
Debt to equity: 0.09210406983855293
Current ratio: 7.349072508147649
Quick ratio: 7.283990640284254
Effective tax rate (%): 34.29765334651175
Interest coverage ratio: 2.1378540181800223
COGS to revenue (%): 57.90198852649292
SG&A to revenue (%): 39.88357333068054
Free cash flow (dilution-adjusted): -82661.04078762306
Buyback yield (%): 0
Retained earnings: 1601652.3206751053
Inventory turnover: 12.038409147855402
Receivables turnover: 0.7536908918914991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0932240571352843
FCF margin (%): -12.87805964023734
Revenue growth (%): -30.506732479655607
Rule of 40 score: -43.38479211989295
Financial ratios for HKIT — annual report dated 2024-12-31
Total revenue: 397938.3561643836
Gross profit: 137792.46575342465
Operating income: -239334.79452054796
Net income: -122834.24657534246
Capital expenditures: 0
Operating cash flow: -94320.27397260274
Depreciation & amortization: 35555.34246575343
Net tangible assets: 4832180.821917809
Owner earnings: -87278.90410958903
Return on net tangible assets (%): -1.8062011196623546
Buffett classification: The Gruesome
Stock price: 71.5
Shares outstanding: 799860
Book value: 4832180.821917809
P/B ratio: 11.835233843195107
Market cap (USD): 57189990
Debt to equity: 0.07184963140951135
Current ratio: 13.081267130665436
Quick ratio: 13.022159136348522
Interest coverage ratio: -5.565269464892638
COGS to revenue (%): 65.37341434448098
SG&A to revenue (%): 94.77027143324325
Free cash flow (dilution-adjusted): -134113.15068493152
Buyback yield (%): 0
Retained earnings: 1437131.2328767125
Inventory turnover: 12.293990457755823
Receivables turnover: 1.0224902448175923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.488047557361165
FCF margin (%): -33.7019914284239
Revenue growth (%): -38.00375805829117
Rule of 40 score: -71.70574948671506
Financial ratios for HKIT — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4832180.821917809
Buffett classification: The Gruesome
Stock price: 71.5
Shares outstanding: 799860
Book value: 4832180.821917809
P/B ratio: 11.835233843195107
Market cap (USD): 57189990
Debt to equity: 0.07184963140951135
Current ratio: 13.081267130665436
Quick ratio: 13.022159136348522
Buyback yield (%): 0
Retained earnings: 1437131.2328767125
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HKIT — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 68.75
Shares outstanding: 799860
Market cap (USD): 54990375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HME.V — annual report dated 2021-12-31
Operating income: 11857480.31496063
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5433070866141732
Shares outstanding: 94387109
Market cap (USD): 51281185.2047244
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HME.V — annual report dated 2022-12-31
Total revenue: 71102205.88235293
Gross profit: 37048529.4117647
Operating income: 32098529.411764704
Net income: 15674264.705882352
Capital expenditures: 12591176.470588235
Operating cash flow: 33155147.058823526
Depreciation & amortization: 5797058.823529411
Net tangible assets: 38970588.23529412
Owner earnings: 8880147.058823528
Return on net tangible assets (%): 22.786792452830184
Capex to operating income (%): 39.226645897283184
Buffett classification: The Good
Stock price: 0.6985294117647058
P/E ratio: 4.2063964699535585
Shares outstanding: 94387109
Book value: 38970588.23529411
P/B ratio: 1.6918444066037737
Market cap (USD): 65932171.72794117
Debt to equity: 0.07428301886792453
Current ratio: 0.7430794744227581
Quick ratio: 0.7430794744227581
Effective tax rate (%): 28.128792987188135
Interest coverage ratio: 46.99031216361679
COGS to revenue (%): 47.89398028935149
SG&A to revenue (%): 6.917341440966298
Free cash flow (dilution-adjusted): 18638970.588235293
Buyback yield (%): 3.77727763427391
Retained earnings: -14314705.88235294
Receivables turnover: 19.958513931888547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 62.19847545771889
FCF margin (%): 26.21433520512105
Rule of 40 score: 26.21433520512105
Financial ratios for HME.V — annual report dated 2023-12-31
Total revenue: 63993939.39393939
Gross profit: 32444696.96969697
Operating income: 28057575.757575758
Net income: 18329545.454545453
Capital expenditures: 0
Operating cash flow: 33515909.09090909
Depreciation & amortization: 6831060.6060606055
Net tangible assets: 46381060.6060606
Owner earnings: 25160606.06060606
Return on net tangible assets (%): 54.24758669127615
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7878787878787878
P/E ratio: 4.057143763587518
Shares outstanding: 94387109
Book value: 46381060.60606061
P/B ratio: 1.6033613733400844
Market cap (USD): 74365601.03030303
Debt to equity: 0.05560001960047693
Current ratio: 1.2550841514726507
Quick ratio: 1.2550841514726507
Effective tax rate (%): 25.475882461652194
Interest coverage ratio: 50.66484268125855
COGS to revenue (%): 49.300359882564635
SG&A to revenue (%): 6.47551851501089
Free cash flow (dilution-adjusted): 22178787.87878788
Buyback yield (%): 4.171650177356316
Retained earnings: -6330303.03030303
Receivables turnover: 14.688228134237523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.68658372095955
FCF margin (%): 34.657638033904725
Revenue growth (%): -9.99725170295703
Rule of 40 score: 24.660386330947695
Financial ratios for HME.V — quarterly report dated 2024-09-30
Operating income: -7013333.333333333
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1925925925925926
Shares outstanding: 94387109
Market cap (USD): 112565367.02962963
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HME.V — annual report dated 2024-12-31
Total revenue: 69884615.38461539
Gross profit: 34867832.167832166
Operating income: 31157342.657342657
Net income: 23148951.04895105
Capital expenditures: 52447.55244755245
Operating cash flow: 32551048.95104895
Depreciation & amortization: 7165034.965034965
Net tangible assets: 52013286.71328671
Owner earnings: 30261538.46153846
Return on net tangible assets (%): 58.1804003818282
Capex to operating income (%): 0.1683312759510717
Buffett classification: The Great
Stock price: 1.125874125874126
P/E ratio: 4.59061853880313
Shares outstanding: 94387109
Book value: 52013286.71328671
P/B ratio: 2.043093420051359
Market cap (USD): 106268003.83916086
Debt to equity: 0.0510224660186343
Current ratio: 2.584748660663399
Quick ratio: 2.584748660663399
Effective tax rate (%): 23.946606625924733
Interest coverage ratio: 59.72520107238606
COGS to revenue (%): 50.10656927002552
SG&A to revenue (%): 4.946215039775854
Free cash flow (dilution-adjusted): 24567832.167832166
Buyback yield (%): 3.644960320595742
Retained earnings: 6324475.524475525
Receivables turnover: 11.04498231653404
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 43.444557120012476
FCF margin (%): 35.154850652924395
Revenue growth (%): 9.205052926049248
Rule of 40 score: 44.35990357897364
Financial ratios for HME.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 190909.0909090909
Buffett classification: The Gruesome
Stock price: 1.125874125874126
Shares outstanding: 94387109
Market cap (USD): 106268003.83916086
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HME.V — quarterly report dated 2025-03-31
Total revenue: 19118181.81818182
Gross profit: 9993706.293706294
Operating income: 9027272.727272728
Net income: 6253146.853146854
Capital expenditures: 783216.7832167832
Operating cash flow: 11315384.615384616
Depreciation & amortization: 2019580.4195804198
Net tangible assets: 55716083.91608392
Owner earnings: 7489510.489510491
Return on net tangible assets (%): 13.442277279915658
Capex to operating income (%): 8.676117437446742
Buffett classification: The Great
Stock price: 1.1398601398601398
P/E ratio: 4.301358411708789
Shares outstanding: 94387109
Book value: 55716083.91608392
P/B ratio: 1.931006196124206
Market cap (USD): 107588103.26573426
Debt to equity: 0.044845244370811055
Current ratio: 1.633606213266163
Quick ratio: 1.633606213266163
Effective tax rate (%): 24.584633549801804
Interest coverage ratio: 72.93220338983052
COGS to revenue (%): 47.72669080800321
SG&A to revenue (%): 4.744138410329565
Free cash flow (dilution-adjusted): 10526573.426573427
Buyback yield (%): 0.8456234306344248
Retained earnings: 10879720.27972028
Receivables turnover: 3.247297778833591
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.038208647698696
FCF margin (%): 55.06053623029372
Rule of 40 score: 55.06053623029372
Financial ratios for HME.V — quarterly report dated 2025-06-30
Total revenue: 17806569.34306569
Gross profit: 8700000
Operating income: 7283211.678832117
Net income: 5148175.182481752
Capital expenditures: 1396350.3649635036
Operating cash flow: 8646715.328467153
Depreciation & amortization: 2169343.0656934306
Net tangible assets: 57783211.678832114
Owner earnings: 5921167.883211679
Return on net tangible assets (%): 10.247211449793465
Capex to operating income (%): 19.17217879334536
Buffett classification: The Great
Stock price: 1.2335766423357664
P/E ratio: 10.212301050365031
Shares outstanding: 94387109
Book value: 57783211.678832114
P/B ratio: 2.015009716786883
Market cap (USD): 116433733
Debt to equity: 0.04316410444273209
Current ratio: 1.616070983500324
Quick ratio: 1.616070983500324
Effective tax rate (%): 25.991605456453303
Interest coverage ratio: 49.64179104477612
COGS to revenue (%): 51.14162738266038
SG&A to revenue (%): 7.604017216642756
Free cash flow (dilution-adjusted): 6848905.109489051
Buyback yield (%): 1.4669539085209025
Retained earnings: 12635036.496350365
Receivables turnover: 3.1352011309600303
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.101746393318148
FCF margin (%): 38.462799754047964
Revenue growth (%): -6.860550274026357
Rule of 40 score: 31.602249480021605
Financial ratios for HME.V — quarterly report dated 2025-09-30
Total revenue: 16648920.863309354
Gross profit: 7984172.661870504
Operating income: 6701438.848920864
Net income: 4986330.9352517985
Capital expenditures: 3016546.762589928
Operating cash flow: 10982014.38848921
Depreciation & amortization: 2059712.2302158275
Net tangible assets: 56805035.97122303
Owner earnings: 4029496.4028776973
Return on net tangible assets (%): 7.093554882913916
Capex to operating income (%): 45.013419216317764
Buffett classification: The Good
Stock price: 1.5035971223021583
P/E ratio: 8.660189822606165
Shares outstanding: 94387109
Book value: 56805035.97122303
P/B ratio: 2.4983733052596913
Market cap (USD): 141920185.47482014
Debt to equity: 0.04043870869691866
Current ratio: 1.4113051470588236
Quick ratio: 1.4113051470588236
Effective tax rate (%): 25.720715893259026
Interest coverage ratio: 46.80904522613065
COGS to revenue (%): 52.04390286059978
SG&A to revenue (%): 7.281133869155647
Free cash flow (dilution-adjusted): 7649640.287769785
Buyback yield (%): 0.9732899935322099
Retained earnings: 13666906.474820144
Receivables turnover: 3.260355029585799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.425847972152516
FCF margin (%): 45.94676346037508
Revenue growth (%): -6.5012437682565345
Rule of 40 score: 39.445519692118545
Financial ratios for HME.V — annual report dated 2025-12-31
Total revenue: 68514598.54014598
Gross profit: 33126277.372262772
Operating income: 28769343.065693427
Net income: 20442335.766423356
Capital expenditures: 0
Operating cash flow: 35154014.59854014
Depreciation & amortization: 8458394.160583941
Net tangible assets: 58826277.37226277
Owner earnings: 28900729.927007295
Return on net tangible assets (%): 49.128945801072064
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3795620437956202
P/E ratio: 6.369764907876883
Shares outstanding: 94387109
Book value: 58826277.37226277
P/B ratio: 2.2135154358993443
Market cap (USD): 130212872.99999997
Debt to equity: 0.03679025213420686
Current ratio: 1.369035883280757
Quick ratio: 1.369035883280757
Effective tax rate (%): 26.078234704112337
Interest coverage ratio: 51.12062256809338
COGS to revenue (%): 51.65077504927289
SG&A to revenue (%): 6.975976135939914
Free cash flow (dilution-adjusted): 24004379.562043793
Buyback yield (%): 3.7299955024948597
Retained earnings: 15850364.963503648
Receivables turnover: 13.382520672939833
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.08761838647295
FCF margin (%): 35.035423214190594
Revenue growth (%): -1.9603983465164965
Rule of 40 score: 33.075024867674095
Financial ratios for HME.V — quarterly report dated 2025-12-31
Total revenue: 13860583.941605838
Gross profit: 5893430.656934306
Operating income: 5262773.722627737
Net income: 3708029.197080292
Capital expenditures: 4972262.773722627
Operating cash flow: 3554744.525547445
Depreciation & amortization: 2091240.8759124086
Net tangible assets: 58826277.37226277
Owner earnings: 827007.299270073
Return on net tangible assets (%): 1.405846734167163
Capex to operating income (%): 94.47988904299584
Buffett classification: The Gruesome
Stock price: 1.3795620437956202
P/E ratio: 6.47964432914864
Shares outstanding: 94387109
Book value: 58826277.37226277
P/B ratio: 2.2135154358993443
Market cap (USD): 130212872.99999997
Debt to equity: 0.03679025213420686
Current ratio: 1.369035883280757
Quick ratio: 1.369035883280757
Effective tax rate (%): 29.129464285714292
Interest coverage ratio: 36.97435897435897
COGS to revenue (%): 57.480646690189054
SG&A to revenue (%): 9.015745958186319
Free cash flow (dilution-adjusted): -1593430.6569343065
Buyback yield (%): 0.612696886718798
Retained earnings: 15850364.963503648
Receivables turnover: 2.7072996863416026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.150295036445678
FCF margin (%): -11.496129338037813
Revenue growth (%): -16.74785377740855
Rule of 40 score: -28.243983115446362
Financial ratios for IVVD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.26
Shares outstanding: 294607452
Market cap (USD): 2138850101.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVVD — annual report dated 2022-12-31
Total revenue: 0
Operating income: -226258000
Net income: -241317000
Capital expenditures: 1705000
Operating cash flow: -219987000
Depreciation & amortization: 462000
Net tangible assets: 355970000
Owner earnings: -242560000
Return on net tangible assets (%): -68.1405736438464
Buffett classification: The Gruesome
Stock price: 1.5
Shares outstanding: 294607452
Book value: 355970000
P/B ratio: 1.2414281484394754
Market cap (USD): 441911178
Debt to equity: 0.01046155574907998
Current ratio: 15.058008069993209
Quick ratio: 15.058008069993209
Free cash flow (dilution-adjusted): -243340000
Buyback yield (%): 0.0009051592716217738
Retained earnings: -533426000
Receivables turnover: 0
Capitalized R&D asset: 179214000
ROCI (R&D-adjusted, %): -19.871964269098353
Rule of 40 score: 0
Financial ratios for IVVD — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -207783000
Net income: -198643000
Capital expenditures: 615000
Operating cash flow: -173164000
Depreciation & amortization: 2028000
Net tangible assets: 177468000
Owner earnings: -197230000
Return on net tangible assets (%): -111.13552865868776
Buffett classification: The Gruesome
Stock price: 3.94
Shares outstanding: 294607452
Book value: 177468000
P/B ratio: 6.540634710933802
Market cap (USD): 1160753360.8799999
Debt to equity: 0.0121993824238736
Current ratio: 4.471595315265157
Quick ratio: 4.471595315265157
Free cash flow (dilution-adjusted): -192464000
Buyback yield (%): 8.615094590308761e-05
Retained earnings: -732069000
Receivables turnover: 0
Capitalized R&D asset: 278731380
ROCI (R&D-adjusted, %): -35.34559508561422
Rule of 40 score: 0
Financial ratios for IVVD — quarterly report dated 2024-09-30
Capital expenditures: 5000
Buffett classification: The Gruesome
Stock price: 1.02
Shares outstanding: 294607452
Market cap (USD): 300499601.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVVD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.44
Shares outstanding: 294607452
Market cap (USD): 129627278.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IVVD — annual report dated 2024-12-31
Total revenue: 25384000
Gross profit: 23766000
Operating income: -176876000
Net income: -169925000
Capital expenditures: 140000
Operating cash flow: -170491000
Depreciation & amortization: 3113000
Net tangible assets: 67539000
Owner earnings: -166952000
Return on net tangible assets (%): -247.19347340055378
Buffett classification: The Gruesome
Stock price: 0.44
Shares outstanding: 294607452
Book value: 67539000
P/B ratio: 1.9192952054368588
Market cap (USD): 129627278.88
Debt to equity: 0.019307363153141147
Current ratio: 1.624515941654834
Quick ratio: 1.624515941654834
COGS to revenue (%): 6.374093917428302
R&D to revenue (%): 540.7106838953672
SG&A to revenue (%): 249.7163567601639
Free cash flow (dilution-adjusted): -190419000
Buyback yield (%): 0
Retained earnings: -901994000
Receivables turnover: 2.2727191333154266
Capitalized R&D asset: 302695480
ROCI (R&D-adjusted, %): -53.47890162292106
Rosenberg metric: 0.14979389630526038
FCF margin (%): -750.1536400882445
Rule of 40 score: -750.1536400882445
Financial ratios for IVVD — quarterly report dated 2025-03-31
Total revenue: 11304000
Gross profit: 10470000
Operating income: -16922000
Net income: -16289000
Capital expenditures: 144000
Operating cash flow: -21129000
Depreciation & amortization: 738000
Net tangible assets: 54149000
Owner earnings: -15695000
Return on net tangible assets (%): -28.984838131821455
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 294607452
Book value: 54149000
P/B ratio: 3.3188155962252304
Market cap (USD): 179710545.72
Debt to equity: 0.01651000018467562
Current ratio: 1.5288839600766206
Quick ratio: 1.5199717713479182
COGS to revenue (%): 7.377919320594479
R&D to revenue (%): 94.13481953290871
SG&A to revenue (%): 148.18648266100496
Free cash flow (dilution-adjusted): -24099000
Buyback yield (%): 0
Retained earnings: -918283000
Inventory turnover: 1.8868778280542986
Receivables turnover: 1.291442933851251
Capitalized R&D asset: 10641000
ROCI (R&D-adjusted, %): -15.169007562895509
FCF margin (%): -213.19002123142252
Rule of 40 score: -213.19002123142252
Financial ratios for IVVD — quarterly report dated 2025-06-30
Total revenue: 11786000
Gross profit: 11101000
Operating income: -15060000
Net income: -14660000
Capital expenditures: 11000
Operating cash flow: -13301000
Depreciation & amortization: 503000
Net tangible assets: 42789000
Owner earnings: -14168000
Return on net tangible assets (%): -33.11131365537872
Buffett classification: The Gruesome
Stock price: 0.71
Shares outstanding: 294607452
Book value: 42789000
P/B ratio: 4.888436068148355
Market cap (USD): 209171290.92
Debt to equity: 0.069293510014256
Current ratio: 1.333625790195946
Quick ratio: 1.3238622303210277
COGS to revenue (%): 5.811980315628712
R&D to revenue (%): 81.22348549126082
SG&A to revenue (%): 140.74325470897676
Free cash flow (dilution-adjusted): -16492000
Buyback yield (%): 0
Retained earnings: -932943000
Inventory turnover: 1.5783410138248848
Receivables turnover: 1.3379498240435919
Capitalized R&D asset: 16702470
ROCI (R&D-adjusted, %): -19.913838643663155
Rosenberg metric: 0.059298938069730286
FCF margin (%): -139.92872900050907
Revenue growth (%): 4.263977353149328
Rule of 40 score: -135.66475164735974
Financial ratios for IVVD — quarterly report dated 2025-09-30
Total revenue: 13129000
Gross profit: 12041000
Operating income: -11023000
Net income: -10470000
Capital expenditures: 0
Operating cash flow: -8250000
Depreciation & amortization: 431000
Net tangible assets: 93068000
Owner earnings: -10039000
Return on net tangible assets (%): -10.786736579705162
Buffett classification: The Gruesome
Stock price: 1.1
Shares outstanding: 294607452
Book value: 93068000
P/B ratio: 3.482058249881807
Market cap (USD): 324068197.20000005
Debt to equity: 0.028763914557098036
Current ratio: 2.466940848615606
Quick ratio: 2.457299532542251
COGS to revenue (%): 8.286998248152944
R&D to revenue (%): 61.28418005941047
SG&A to revenue (%): 114.3879960393023
Free cash flow (dilution-adjusted): -11323000
Buyback yield (%): 0
Retained earnings: -943413000
Inventory turnover: 2.536130536130536
Receivables turnover: 1.2955397671205842
Capitalized R&D asset: 17971440
ROCI (R&D-adjusted, %): -11.006500378573184
Rosenberg metric: 0.09819283401232634
FCF margin (%): -86.24419224617259
Revenue growth (%): 11.39487527575089
Rule of 40 score: -74.8493169704217
Financial ratios for IVVD — quarterly report dated 2025-12-31
Total revenue: 17207000
Gross profit: 16067000
Operating income: -12555000
Net income: -11070000
Capital expenditures: 0
Operating cash flow: -15455000
Depreciation & amortization: 435000
Net tangible assets: 241540000
Owner earnings: -10635000
Return on net tangible assets (%): -4.402997433137369
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 294607452
Book value: 241540000
P/B ratio: 3.0126703918191606
Market cap (USD): 727680406.44
Debt to equity: 0.010325411940051337
Current ratio: 7.243713959546878
Quick ratio: 7.236015572402892
COGS to revenue (%): 6.6252106700761315
R&D to revenue (%): 58.39483930958331
SG&A to revenue (%): 107.94444121578428
Free cash flow (dilution-adjusted): -18019000
Buyback yield (%): 0
Retained earnings: -954483000
Inventory turnover: 4.334600760456274
Receivables turnover: 1.178965399109284
Capitalized R&D asset: 18597910
ROCI (R&D-adjusted, %): -4.488530209557138
Rosenberg metric: 0.5003728560775541
FCF margin (%): -104.71900970535248
Revenue growth (%): 31.061009977911493
Rule of 40 score: -73.65799972744098
Financial ratios for IVVD — annual report dated 2025-12-31
Total revenue: 53426000
Gross profit: 49679000
Operating income: -55560000
Net income: -52489000
Capital expenditures: 155000
Operating cash flow: -58135000
Depreciation & amortization: 2107000
Net tangible assets: 241540000
Owner earnings: -50537000
Return on net tangible assets (%): -20.922828517015816
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 294607452
Book value: 241540000
P/B ratio: 3.0126703918191606
Market cap (USD): 727680406.44
Debt to equity: 0.010325411940051337
Current ratio: 7.243713959546878
Quick ratio: 7.236015572402892
COGS to revenue (%): 7.013439149477782
R&D to revenue (%): 71.7029161831318
SG&A to revenue (%): 125.27795455396249
Free cash flow (dilution-adjusted): -69933000
Buyback yield (%): 0.08698873769280102
Retained earnings: -954483000
Inventory turnover: 14.247148288973383
Receivables turnover: 3.6605686879068173
Capitalized R&D asset: 182625320
ROCI (R&D-adjusted, %): -30.248050376260554
Rosenberg metric: 0.18879595494484677
FCF margin (%): -130.8969415640325
Revenue growth (%): 110.47116293728332
Rule of 40 score: -20.425778626749164
Financial ratios for KFM.AX — annual report dated 2021-06-30
Total revenue: 239.84962406015038
Gross profit: 239.84962406015038
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14285714285714285
Shares outstanding: 104072502
Market cap (USD): 14867500.285714285
COGS to revenue (%): 0
Buyback yield (%): 2.6960759377251504
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KFM.AX — annual report dated 2022-06-30
Total revenue: 1868.9655172413793
Gross profit: 1868.9655172413793
Operating income: -615013.7931034483
Net income: -617997.2413793104
Capital expenditures: 6242.758620689656
Depreciation & amortization: 29715.862068965518
Net tangible assets: 3034785.5172413792
Owner earnings: -594524.1379310344
Return on net tangible assets (%): -19.59031814780298
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
Shares outstanding: 104072502
Book value: 3008653.103448276
P/B ratio: 5.963975975502384
Market cap (USD): 17943534.827586208
Debt to equity: 0.04529326560837053
Current ratio: 11.076264241595526
Quick ratio: 11.076264241595526
Interest coverage ratio: -206.14193250115582
COGS to revenue (%): 0
SG&A to revenue (%): 15427.0110701107
Free cash flow (dilution-adjusted): -1459984.1379310344
Buyback yield (%): 0.01728026102418485
Retained earnings: -1476916.551724138
Receivables turnover: 0.04562289562289562
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.763788409980982
FCF margin (%): -78117.23247232473
Revenue growth (%): 679.2238676899796
Rule of 40 score: -77438.00860463476
Financial ratios for KFM.AX — annual report dated 2023-06-30
Total revenue: 44436.4238410596
Gross profit: 44436.4238410596
Operating income: -1331350.9933774834
Net income: -1333743.0463576159
Capital expenditures: 73104.63576158941
Depreciation & amortization: 34815.23178807947
Net tangible assets: 5019566.225165563
Owner earnings: -1372032.4503311259
Return on net tangible assets (%): -27.33368559722253
Buffett classification: The Gruesome
Stock price: 0.1920529801324503
Shares outstanding: 104072502
Book value: 5019566.225165563
P/B ratio: 3.981904663142708
Market cap (USD): 19987434.158940397
Debt to equity: 0.010344948146623578
Current ratio: 15.35531117877719
Quick ratio: 15.35531117877719
Interest coverage ratio: -556.5725359911407
COGS to revenue (%): 0
SG&A to revenue (%): 2179.3767418292377
Free cash flow (dilution-adjusted): -2090959.6026490065
Buyback yield (%): 1.2124836481451338
Retained earnings: -2751975.4966887417
Receivables turnover: 0.867595908920467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.33418719392504
FCF margin (%): -4705.508278811904
Revenue growth (%): 2277.59463356223
Rule of 40 score: -2427.9136452496746
Financial ratios for KFM.AX — annual report dated 2024-06-30
Operating income: -772202.6666666666
Net income: -1242351.3333333333
Capital expenditures: 5.333333333333333
Depreciation & amortization: 43746.666666666664
Net tangible assets: 3834012
Owner earnings: -1198609.9999999998
Return on net tangible assets (%): -31.26255212555411
Buffett classification: The Gruesome
Stock price: 0.04666666666666667
Shares outstanding: 104072502
Book value: 3834012
P/B ratio: 1.2667453205675934
Market cap (USD): 4856716.76
Debt to equity: 0.008753406788154722
Current ratio: 22.487259502054194
Quick ratio: 22.487259502054194
Interest coverage ratio: -260.5858267716535
Free cash flow (dilution-adjusted): -1343271.3333333333
Buyback yield (%): 0
Retained earnings: -3611423.3333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.049022399335055
Rule of 40 score: 0
Financial ratios for KRT — annual report dated 2021-12-31
Capital expenditures: 12381000
Depreciation & amortization: 10044000
Buffett classification: The Gruesome
Stock price: 15.95
Shares outstanding: 19963731
Market cap (USD): 318421509.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRT — annual report dated 2022-12-31
Total revenue: 422957000
Gross profit: 132086000
Operating income: 29983000
Net income: 25837000
Capital expenditures: 14670000
Operating cash flow: 29474000
Depreciation & amortization: 14227000
Net tangible assets: 137819000
Owner earnings: 25394000
Return on net tangible assets (%): 18.425616206763944
Capex to operating income (%): 48.92772571123637
Buffett classification: The Good
Stock price: 11.63
P/E ratio: 8.986267427719937
Shares outstanding: 19963731
Book value: 151933000
P/B ratio: 1.5281616997623952
Market cap (USD): 232178191.53
Debt to equity: 0.3860188372506302
Current ratio: 3.1538990650396146
Quick ratio: 1.339872111685731
Effective tax rate (%): 20.533325131485867
Interest coverage ratio: 14.865146256817056
COGS to revenue (%): 68.77082067444208
SG&A to revenue (%): 24.140279035457503
Free cash flow (dilution-adjusted): 12680000
Buyback yield (%): 0
Retained earnings: 56118000
Inventory turnover: 4.084922618880431
Receivables turnover: 14.140044129446377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.081682494058857
FCF margin (%): 2.997940689006211
Rule of 40 score: 2.997940689006211
Financial ratios for KRT — annual report dated 2023-12-31
Total revenue: 405651000
Gross profit: 153043000
Operating income: 44601000
Net income: 33180000
Capital expenditures: 8489000
Operating cash flow: 53379000
Depreciation & amortization: 15752000
Net tangible assets: 150281000
Owner earnings: 40443000
Return on net tangible assets (%): 26.911585629587243
Capex to operating income (%): 19.03320553350822
Buffett classification: The Great
Stock price: 21.2
P/E ratio: 12.755608716094033
Shares outstanding: 19963731
Book value: 162690000
P/B ratio: 2.6014573557071734
Market cap (USD): 423231097.2
Debt to equity: 0.4364435429344151
Current ratio: 3.48931330375442
Quick ratio: 1.8783585955271278
Effective tax rate (%): 22.80848687883864
Interest coverage ratio: 21.831130690161526
COGS to revenue (%): 62.27224880500726
SG&A to revenue (%): 25.751446440413066
Free cash flow (dilution-adjusted): 43279000
Buyback yield (%): 0
Retained earnings: 67679000
Inventory turnover: 3.5315960183424675
Receivables turnover: 14.611209163274863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.224900429317746
FCF margin (%): 10.669023372307723
Revenue growth (%): -4.091668893055322
Rule of 40 score: 6.577354479252401
Financial ratios for KRT — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1099000
Buffett classification: The Gruesome
Stock price: 23.04
Shares outstanding: 19963731
Market cap (USD): 459964362.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRT — annual report dated 2024-12-31
Total revenue: 422633000
Gross profit: 164329000
Operating income: 40513000
Net income: 30824000
Capital expenditures: 3934000
Operating cash flow: 47982000
Depreciation & amortization: 18297000
Net tangible assets: 156045000
Owner earnings: 45187000
Return on net tangible assets (%): 28.957672466275753
Capex to operating income (%): 9.710463308073953
Buffett classification: The Great
Stock price: 27.31
P/E ratio: 17.687824215221905
Shares outstanding: 19963731
Book value: 0
Market cap (USD): 545209493.61
Current ratio: 3.4662518569552394
Quick ratio: 1.9436131504725818
Effective tax rate (%): 24.256051111930212
Interest coverage ratio: 19.082901554404145
COGS to revenue (%): 61.11780197003074
SG&A to revenue (%): 28.287426679885385
Free cash flow (dilution-adjusted): 41849000
Buyback yield (%): 0
Retained earnings: 66340000
Inventory turnover: 3.6523853963406014
Receivables turnover: 15.80763764213046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.33094830192482
FCF margin (%): 9.901971687019234
Revenue growth (%): 4.1863572381184815
Rule of 40 score: 14.088328925137716
Financial ratios for KRT — quarterly report dated 2024-12-31
Capital expenditures: 743000
Depreciation & amortization: 4843000
Buffett classification: The Gruesome
Stock price: 27.31
Shares outstanding: 19963731
Market cap (USD): 545209493.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRT — quarterly report dated 2025-03-31
Total revenue: 103624000
Gross profit: 40762000
Operating income: 7803000
Net income: 6815000
Capital expenditures: 1037000
Operating cash flow: 7726000
Depreciation & amortization: 4941000
Net tangible assets: 149504000
Owner earnings: 10719000
Return on net tangible assets (%): 7.16970783390411
Capex to operating income (%): 13.28976034858388
Buffett classification: The Great
Stock price: 24.34
P/E ratio: 17.825282925165077
Shares outstanding: 19963731
Book value: 160211000
P/B ratio: 3.032982832264951
Market cap (USD): 485917212.54
Debt to equity: 0.6286022807422711
Current ratio: 2.862357072716076
Quick ratio: 1.532430138308673
Effective tax rate (%): 23.735452103849596
Interest coverage ratio: 15.330058939096267
COGS to revenue (%): 60.66355284490079
SG&A to revenue (%): 30.713927275534626
Free cash flow (dilution-adjusted): 6284000
Buyback yield (%): 0
Retained earnings: 63732000
Inventory turnover: 0.7866993717618201
Receivables turnover: 3.1981728958982747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.09479520729139
FCF margin (%): 6.064232224195167
Rule of 40 score: 6.064232224195167
Financial ratios for KRT — quarterly report dated 2025-06-30
Total revenue: 123986000
Gross profit: 49107000
Operating income: 16267000
Net income: 11052000
Capital expenditures: 249000
Operating cash flow: 9750000
Depreciation & amortization: 5323000
Net tangible assets: 152050000
Owner earnings: 16126000
Return on net tangible assets (%): 10.605721802038804
Capex to operating income (%): 1.5307063379848773
Buffett classification: The Great
Stock price: 26.17
P/E ratio: 29.24110596462753
Shares outstanding: 19963731
Book value: 162706000
P/B ratio: 3.211011519366219
Market cap (USD): 522450840.27000004
Debt to equity: 0.6031062161198727
Current ratio: 2.679947624392069
Quick ratio: 1.402515180292958
Effective tax rate (%): 23.837089104817036
Interest coverage ratio: 31.222648752399234
COGS to revenue (%): 60.39310889939187
SG&A to revenue (%): 26.486861419837727
Free cash flow (dilution-adjusted): 9138000
Buyback yield (%): 0
Retained earnings: 65632000
Inventory turnover: 0.8434314421203213
Receivables turnover: 3.407613027346434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.468892291173722
FCF margin (%): 7.370186956591873
Revenue growth (%): 19.649888056820814
Rule of 40 score: 27.020075013412686
Financial ratios for KRT — quarterly report dated 2025-09-30
Total revenue: 124516000
Gross profit: 42918000
Operating income: 8170000
Net income: 7603000
Capital expenditures: 2254000
Operating cash flow: 982000
Depreciation & amortization: 5427000
Net tangible assets: 150691000
Owner earnings: 10776000
Return on net tangible assets (%): 7.151057461958578
Capex to operating income (%): 27.58873929008568
Buffett classification: The Good
Stock price: 23.84
P/E ratio: 18.686114921083625
Shares outstanding: 19963731
Book value: 161586000
P/B ratio: 2.9453996450187514
Market cap (USD): 475935347.04
Debt to equity: 0.5695419157600287
Current ratio: 2.144100798954826
Quick ratio: 1.087194110848701
Effective tax rate (%): 23.256283435954376
Interest coverage ratio: 15.15769944341373
COGS to revenue (%): 65.53214044781393
SG&A to revenue (%): 26.9587844132481
Free cash flow (dilution-adjusted): -1772000
Buyback yield (%): 0
Retained earnings: 63909000
Inventory turnover: 0.9698576081013621
Receivables turnover: 3.2881588676455054
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6598531579112406
FCF margin (%): -1.4231102830158373
Revenue growth (%): 0.42746761731163196
Rule of 40 score: -0.9956426657042053
Financial ratios for KRT — annual report dated 2025-12-31
Total revenue: 467743000
Gross profit: 172136000
Operating income: 40921000
Net income: 32664000
Capital expenditures: 4505000
Operating cash flow: 33815000
Depreciation & amortization: 21118000
Net tangible assets: 152643000
Owner earnings: 49277000
Return on net tangible assets (%): 32.28251541177781
Capex to operating income (%): 11.00901737494196
Buffett classification: The Great
Stock price: 21.81
P/E ratio: 13.329934273512123
Shares outstanding: 19963731
Book value: 0
Market cap (USD): 435408973.10999995
Current ratio: 2.2954713756764455
Quick ratio: 1.1322415266305896
Effective tax rate (%): 24.07605411184975
Interest coverage ratio: 19.912895377128955
COGS to revenue (%): 63.19859409975136
SG&A to revenue (%): 27.071276320543546
Free cash flow (dilution-adjusted): 28128000
Buyback yield (%): 0.6885480514069694
Retained earnings: 61704000
Inventory turnover: 3.618998065669303
Receivables turnover: 12.849376407889677
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.81719441200004
FCF margin (%): 6.013558727762895
Revenue growth (%): 10.673563115043075
Rule of 40 score: 16.687121842805972
Financial ratios for KRT — quarterly report dated 2025-12-31
Total revenue: 115617000
Gross profit: 39349000
Operating income: 8681000
Net income: 7194000
Capital expenditures: 741000
Operating cash flow: 15357000
Depreciation & amortization: 5427000
Net tangible assets: 152643000
Owner earnings: 11880000
Return on net tangible assets (%): 7.782865902792791
Capex to operating income (%): 8.535882962792304
Buffett classification: The Great
Stock price: 21.81
P/E ratio: 13.329934273512123
Shares outstanding: 19963731
Book value: 0
Market cap (USD): 435408973.10999995
Current ratio: 2.2954713756764455
Quick ratio: 1.1322415266305896
Effective tax rate (%): 25.5895738518825
Interest coverage ratio: 17.862139917695472
COGS to revenue (%): 65.96607765294031
SG&A to revenue (%): 25.538631862096405
Free cash flow (dilution-adjusted): 14478000
Buyback yield (%): 0
Retained earnings: 61704000
Inventory turnover: 0.9337185671261722
Receivables turnover: 3.1761166968847867
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9918883871501754
FCF margin (%): 12.522379926827371
Revenue growth (%): -7.146872691059783
Rule of 40 score: 5.375507235767588
Financial ratios for LITH.V — annual report dated 2021-12-31
Capital expenditures: 98123.62204724409
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.5826771653543307
Shares outstanding: 223222468
Market cap (USD): 130066634.89763778
Buyback yield (%): 0
Capitalized R&D asset: 901251.1811023622
Rule of 40 score: 0
Financial ratios for LITH.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -7019.117647058823
Operating income: -5161081.617647058
Net income: -1557650.7352941176
Capital expenditures: 477969.85294117645
Operating cash flow: -567040.4411764706
Depreciation & amortization: 7019.117647058823
Net tangible assets: 38904349.26470588
Owner earnings: -2028601.4705882352
Return on net tangible assets (%): -5.214330811153259
Buffett classification: The Gruesome
Stock price: 0.4191176470588235
Shares outstanding: 223222468
Book value: 38904349.264705874
P/B ratio: 2.404781915828064
Market cap (USD): 93556475.55882353
Debt to equity: 0
Current ratio: 23.66099360961054
Quick ratio: 23.66099360961054
Free cash flow (dilution-adjusted): -2789074.2647058824
Buyback yield (%): 0
Retained earnings: -10788200.735294117
Receivables turnover: 0
Capitalized R&D asset: 2331102.9972209353
ROCI (R&D-adjusted, %): -10.452144059718266
Rule of 40 score: 0
Financial ratios for LITH.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -26946.969696969696
Operating income: -5297593.181818182
Net income: 354228.78787878784
Capital expenditures: 518086.3636363636
Operating cash flow: -792553.0303030303
Depreciation & amortization: 26946.969696969696
Net tangible assets: 39006493.18181818
Owner earnings: -136910.60606060602
Return on net tangible assets (%): -0.3509943983491015
Buffett classification: The Gruesome
Stock price: 0.3939393939393939
P/E ratio: 248.2466890513322
Shares outstanding: 223222468
Book value: 40201055.3030303
P/B ratio: 2.187408342759282
Market cap (USD): 87936123.75757575
Debt to equity: 0
Current ratio: 10.807747465720166
Quick ratio: 10.807747465720166
Effective tax rate (%): -11.294599290695736
Free cash flow (dilution-adjusted): -3643856.8181818184
Buyback yield (%): 0
Retained earnings: -11955449.242424242
Receivables turnover: 0
Capitalized R&D asset: 2036957.5154322286
ROCI (R&D-adjusted, %): -13.45194157717554
Rosenberg metric: -0.011537231081052491
Rule of 40 score: 0
Financial ratios for LITH.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4
Shares outstanding: 223222468
Market cap (USD): 89288987.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LITH.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -30173.426573426575
Operating income: -2566902.097902098
Net income: 6537194.405594406
Capital expenditures: 720821.6783216783
Operating cash flow: 36267.832167832166
Depreciation & amortization: 30173.426573426575
Net tangible assets: 30815116.783216786
Owner earnings: 5846546.153846154
Return on net tangible assets (%): 18.97298068015251
Buffett classification: The Gruesome
Stock price: 0.5384615384615385
P/E ratio: 18.38659003862567
Shares outstanding: 223222468
Book value: 33637027.27272727
P/B ratio: 3.573345306763075
Market cap (USD): 120196713.53846155
Debt to equity: 0
Current ratio: 1.4116433695628035
Quick ratio: 1.4116433695628035
Effective tax rate (%): 17.765338241744285
Free cash flow (dilution-adjusted): -850623.7762237762
Buyback yield (%): 0
Retained earnings: -10115162.237762239
Receivables turnover: 0
Capitalized R&D asset: 960123.1256684491
ROCI (R&D-adjusted, %): -9.140017946344313
Rosenberg metric: -0.005541100481811332
Rule of 40 score: 0
Financial ratios for LITH.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5384615384615385
Shares outstanding: 223222468
Market cap (USD): 120196713.53846155
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LITH.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -3747.5524475524476
Operating income: -291903.49650349654
Net income: 2712809.090909091
Capital expenditures: 0
Operating cash flow: -85417.48251748252
Depreciation & amortization: 3747.5524475524476
Net tangible assets: 35515822.37762238
Owner earnings: 2716556.643356643
Return on net tangible assets (%): 7.6488631305586114
Buffett classification: The Gruesome
Stock price: 0.39160839160839167
P/E ratio: 8.055837024919594
Shares outstanding: 223222468
Book value: 38528110.48951049
P/B ratio: 2.268883434814047
Market cap (USD): 87415791.66433568
Debt to equity: 0
Current ratio: 0.7970693055615113
Quick ratio: 0.7970693055615113
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -94201.39860139861
Buyback yield (%): 0
Retained earnings: -7505851.048951049
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7218545475416727
Rule of 40 score: 0